28.12.2012 Views

Bulletin 2010/35 - European Patent Office

Bulletin 2010/35 - European Patent Office

Bulletin 2010/35 - European Patent Office

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

(C07D) I.1(1)<br />

• 3-HETEROCYCLIC SUBSTITUTED INDOLE<br />

DERIVATIVES AND METHODS OF USE<br />

THEREOF<br />

• DÉRIVÉS D'INDOLE À SUBSTITUTION<br />

HÉTÉROCYCLIQUE EN POSITION 3 ET<br />

LEURS PROCÉDÉS D'UTILISATION<br />

(71) Schering Corporation, 2000 Galloping Hill<br />

Road, Kenilworth, NJ 07033-0530, US<br />

(72) CHAN, Tin-Yau, Edison New Jersey 08817,<br />

US<br />

DUCA, Jose, S., Cranford New Jersey 07016,<br />

US<br />

HONG, Liwu, Edison New Jersey 08817, US<br />

LESBURG, Charles, A., Short Hills New<br />

Jersey 07078, US<br />

MCKITTRICK, Brian, A., New Vernon New<br />

Jersey 07976, US<br />

PU, Haiyan, Livingston New Jersey 07039,<br />

US<br />

WANG, Li, Nanuet New York 10954, US<br />

VACCARO, Henry, M., South Plainfield New<br />

Jersey 07080, US<br />

(74) van den Broek, Ludovicus A.G.M., et al, P.O.<br />

Box 20, 5340 BH Oss, NL<br />

C07D 401/04 → (51) C07D 207/16<br />

(51) C07D 401/06 (11) 2 222 661 A2*<br />

C07D 471/04 A61K 31/44<br />

A61P 31/18<br />

(25) En (26) En<br />

(21) 08851089.6 (22) 14.11.2008<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MT NL<br />

NO PL PT RO SE SI SK TR<br />

AL BA MK RS<br />

(86) US 2008/012774 14.11.2008<br />

(87) WO 2009/067166 2009/22 28.05.2009<br />

(88) 16.07.2009<br />

(30) 20.11.2007 US 3769<br />

(54) • NICHT-NUKLEOSIDISCHE REVERSE-<br />

TRANSKRIPTASE-HEMMER<br />

• NON-NUCLEOSIDE REVERSE TRAN-<br />

SCRIPTASE INHIBITORS<br />

• INHIBITEURS NON-NUCLÉOSIDIQUES DE<br />

LA TRANSCRIPTASE INVERSE<br />

(71) Merck Sharp & Dohme Corp., 126 East<br />

Lincoln Avenue, Rahway, NJ 07065, US<br />

(72) TUCKER, Thomas, J., Rahway New Jersey<br />

07065-0907, US<br />

TYNEBOR, Robert, Rahway New Jersey<br />

07065-0907, US<br />

SISKO, John, T., Rahway New Jersey 07065-<br />

0907, US<br />

ANTHONY, Neville, Rahway New Jersey<br />

07065-0907, US<br />

GOMEZ, Robert, Rahway New Jersey 07065-<br />

0907, US<br />

JOLLY, Samson, M., Rahway New Jersey<br />

07065-0907, US<br />

(74) Horgan, James Michael Frederic, Merck &<br />

Co., Inc. <strong>European</strong> <strong>Patent</strong> Department Merck<br />

Sharpe & Dohme Limited Hertford Road,<br />

Hoddesdon Hertfordshire EN11 9BU, GB<br />

C07D 401/06 → (51) C07D 207/16<br />

(51) C07D 401/10 (11) 2 222 662 A2*<br />

(25) En (26) En<br />

(21) 08850245.5 (22) 13.11.2008<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MT NL<br />

NO PL PT RO SE SI SK TR<br />

AL BA MK RS<br />

(86) US 2008/083321 13.11.2008<br />

(87) WO 2009/064836 2009/21 22.05.2009<br />

(88) 02.07.2009<br />

(30) 15.11.2007 US 988231 P<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

(54) • INHIBITOREN DER KYNURENIN-AMINOT-<br />

RANSFERASE<br />

• KYNURENINE-AMINOTRANSFERASE INHI-<br />

BITORS<br />

• INHIBITEURS DE LA KYNURÉNINE-AMI-<br />

NOTRANSFÉRASE<br />

(71) University of Maryland, Baltimore, 520 West<br />

Lombard Street, Baltimore MD 21201, US<br />

Mitsubishi Tanabe Pharma Corporation, 2-<br />

10, Dosho-machi 3-chome, Chuo-ku Osakashi<br />

Osaka 541-8505, JP<br />

(72) SCHWARCZ, Robert, Baltimore MD 21208,<br />

US<br />

KAJII, Yasushi, Osaka 541-8505, JP<br />

ONO, Shin-ichiro, Osaka 541-8505, JP<br />

(74) Kröncke, Rolf, et al, Gramm, Lins & Partner<br />

<strong>Patent</strong>- und Rechtsanwaltssozietät GbR<br />

Freundallee 13a, 30173 Hannover, DE<br />

C07D 401/10 → (51) C07D 239/22<br />

C07D 401/10 → (51) C07D 239/48<br />

C07D 401/10 → (51) C07F 17/02<br />

(51) C07D 401/12 (11) 2 222 663 A1*<br />

(25) En (26) En<br />

(21) 08870010.9 (22) 18.12.2008<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MT NL<br />

NO PL PT RO SE SI SK TR<br />

AL BA MK RS<br />

(86) IN 2008/000842 18.12.2008<br />

(87) WO 2009/087672 2009/29 16.07.2009<br />

(30) 18.12.2007 IN MU24892007<br />

(54) • VERFAHREN ZUR HERSTELLUNG VON<br />

STABILEM AMORPHEM R-LANSOPRAZOL<br />

• A PROCESS FOR PREPARATION OF<br />

STABLE AMORPHOUS R-LANSOPRAZOLE<br />

• PROCÉDÉ DE PRÉPARATION DE R-LAN-<br />

SOPRAZOLE AMORPHE STABLE<br />

(71) Watson Pharma Private Limited, 201/301,<br />

Corporate Enclave HDO-Corporate Bldg, B<br />

Wing B.D. Sawant Marg, Chakala Off Wester<br />

Express Highway Andheri (East), Mumbai<br />

400 099, IN<br />

(72) NAIK, Samir, Thane 400 604 Maharashtra, IN<br />

BODKE, Arjun, Ulhasnagar 3, IN<br />

MAHAJAN, Kishor, Maharashtra, IN<br />

BHANU, Manjunath, Narayan, Pune 211 021<br />

Maharashtra, IN<br />

(74) Shaw, Matthew Nigel, Forrester & Boehmert<br />

Pettenkoferstrasse 20-22, 80336 München,<br />

DE<br />

C07D 401/12 → (51) C07D 239/48<br />

(51) C07D 401/14 (11) 2 222 664 A1*<br />

C07D 407/14 C07D 409/14<br />

A61K 31/495 A61P 25/00<br />

(25) En (26) En<br />

(21) 08852442.6 (22) 17.11.2008<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MT NL<br />

NO PL PT RO SE SI SK TR<br />

AL BA MK RS<br />

(86) US 2008/083764 17.11.2008<br />

(87) WO 2009/067401 2009/22 28.05.2009<br />

(30) 20.11.2007 US 989246 P<br />

(54) • CYCLOALKYLOXY- UND HETEROCYC-<br />

LOALKYLOXYPYRIDINVERBINDUNGEN<br />

ALS MODULATOREN DES HISTAMIN-H3-<br />

REZEPTORS<br />

• CYCLOALKYLOXY-AND HET ROCY-<br />

CLOALKY- LOXYPYRIDINE COMPOUNDS<br />

AS MODULATORS OF THE HISTAMINE H3<br />

RECEPTOR<br />

88<br />

Anmeldungen<br />

Applications<br />

Demandes (<strong>35</strong>/<strong>2010</strong>) 01.09.<strong>2010</strong><br />

• COMPOSÉS CYCLOALKYLOXY-PYRIDINE<br />

ET HÉTÉROCYCLOALKYLOXY-PYRIDINE<br />

COMME MODULATEURS DU RÉCEPTEUR<br />

H3 DE L'HISTAMINE<br />

(71) Janssen Pharmaceutica, N.V., Turnhoutseweg<br />

30, 2340 Beerse, BE<br />

(72) LETAVIC, Michael A., San Diego California<br />

92130, US<br />

STOCKING, Emily M., Encinitas California<br />

92024, US<br />

(74) Warner, James Alexander, Carpmaels &<br />

Ransford One Southampton Row, London<br />

WC1B 5HA, GB<br />

C07D 403/04 → (51) C07D 401/04<br />

(51) C07D 403/06 (11) 2 222 665 A1*<br />

C07D 409/14 A61K 31/41<br />

A61P 15/00<br />

(25) En (26) En<br />

(21) 08849494.3 (22) 06.11.2008<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MT NL<br />

NO PL PT RO SE SI SK TR<br />

AL BA MK RS<br />

(86) IB 2008/054634 06.11.2008<br />

(87) WO 2009/063365 2009/21 22.05.2009<br />

(30) 15.11.2007 US 988184 P<br />

(54) • AZETIDINE ALS EP-2-ANTAGONISTEN<br />

• AZETIDINES AS EP2 ANTAGONISTS<br />

• AZÉTIDINES COMME ANTAGOSNISTES DE<br />

L' EP2<br />

(71) Pfizer Limited, Ramsgate Road, Sandwich,<br />

Kent CT13 9NJ, GB<br />

(72) SKERRATT, Sarah Elizabeth, Sandwich Kent<br />

CT13 9NJ, GB<br />

DACK, Kevin Neil, Sandwich Kent CT13 9NJ,<br />

GB<br />

(74) Cosway, Sarah Michelle, Pfizer Limited<br />

<strong>European</strong> <strong>Patent</strong> Department Ramsgate<br />

Road, Sandwich, Kent CT13 9NJ, GB<br />

C07D 403/06 → (51) C07D 241/24<br />

C07D 403/10 → (51) C07D 239/22<br />

C07D 403/10 → (51) C07D 239/48<br />

C07D 403/12 → (51) C07D 239/48<br />

C07D 403/14 → (51) C07D 239/48<br />

C07D 403/14 → (51) C07D 401/04<br />

C07D 405/06 → (51) C07D 455/02<br />

C07D 405/10 → (51) C07D 309/28<br />

(51) C07D 405/12 (11) 2 222 666 A1*<br />

A61P 9/12 A61P 13/08<br />

A61K 31/517<br />

(25) En (26) En<br />

(21) 08775904.9 (22) 10.07.2008<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MT NL<br />

NO PL PT RO SE SI SK TR<br />

AL BA MK RS<br />

(86) GB 2008/002362 10.07.2008<br />

(87) WO 2009/081087 2009/27 02.07.2009<br />

(30) 24.12.2007 IN MU25372007<br />

(54) • KRISTALLINES POLYMORPH VON DOXA-<br />

ZOSIN-MESYLAT (FORM IV) UND VER-<br />

FAHREN ZU DEREN HERSTELLUNG<br />

• CRYSTALLINE POLYMORPH OF DOXAZO-<br />

SIN MESYLATE (FORM IV) AND PROCESS<br />

FOR PREPARATION THEREOF

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!